Caribou Biosciences, Inc. (CRBU)

1.555 +0.02 (+0.97%) USD  |  NASDAQ  |  Sep 01, 16:00
1.61 +0.06 (+3.54%) After-Hours: 19:15
More

Caribou Biosciences Beta (5Y)

Beta (5Y) Chart

View Beta (5Y) for CRBU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Beta (5Y) Chart
Start Trial

Historical Beta (5Y) Data

View and export this data back to 2026. Start Trial.
Date Value
August 31, 2026 --
Date Value
July 31, 2026 --

Beta Definition

Beta is a risk metric that measures the risk associated with a security in comparison to the risk associated with the market overall. A beta of 1 would signify that the beta is neutral with the market. A common use of beta is within the Capital Asset Pricing Model (CAPM), to find a security's expected return.

Read full definition.

Beta (5Y) Range, Past 5 Years

View Beta (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Beta (5Y) Benchmarks

View Beta (5Y) Benchmarks
Start Trial
Intellia Therapeutics, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade
Sangamo Therapeutics, Inc. Upgrade

Beta (5Y) Related Metrics

Alpha (5Y) Upgrade
Annualized Standard Deviation of Monthly Returns (5Y Lookback) Upgrade
Historical Sharpe Ratio (5Y) Upgrade
Historical Sortino (5Y) Upgrade
Max Drawdown (5Y) Upgrade
Monthly Value at Risk (VaR) 5% (5Y Lookback) Upgrade